Rakuten Medical's Anti-PD-L1 Antibody-IR700 Conjugate, RM-0256, Selected for AMED Funding ...Middle East

News by : (PR Newswire) -

AMED grant to support the clinical development of RM-0256 photoimmunotherapy for targeting malignant epithelial tumors Targeting PD-L1, pre-clinical observations indicate RM-0256 harnesses a triple mechanism of action, with potential applications across a broad range of solid tumors,...

Read More Details
Finally We wish PressBee provided you with enough information of ( Rakuten Medical's Anti-PD-L1 Antibody-IR700 Conjugate, RM-0256, Selected for AMED Funding )

Also on site :

Most Viewed News
جديد الاخبار